ABT achieved advancements of their new product pipeline, including several recent launches in large, high growth markets. In August, Abbott announced U.S. FDA approval...
BSX structural heart programs are fast building momentum, banking on strong performance of the WATCHMAN left atrial appendage closure device and ACURATE TAVR valve....
MDT increased their investments at the front end of major product launches in surgical robots and renal denervation, which represent large, new markets for...
The company’s cloud based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care,...
The company is experiencing high demand for REGEN COV, its COVID 19 therapy. The therapy, REGEN COV, have been authorized in the United States...
Baxter has experienced lower demand for many of its products and treatments as healthcare has prioritized COVID 19 related products. The company does have...
In Jul 21, AMEH’s affiliate AP AMH 2 Medical Corporation has entered into a definitive agreement to acquire 80% of the fully diluted capitalization...
BDX acquired ZebraSci , a pharmaceutical services company. This acquisition provides the opportunity to expand their Pharmaceutical Systems business beyond injectable device design and...
Boutique equity research firm providing Business, Investment and M&A research services focused on fast growing Technology, Healthcare, Life science and Industrial sectors.